SNAR-B2

Summary

SNAR-B2 (small NF90 (ILF3) associated RNA B2, HGNC:34318) is a gene on chromosome 19q13.33.

Predicted to be located in cytoplasm and nucleus.

Source: NCBI Gene 100170217 — RefSeq curated summary.

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:34318
Approved symbol	SNAR-B2
Name	small NF90 (ILF3) associated RNA B2
Location	19q13.33
Locus type	RNA, ribosomal
Status	Approved
Entrez	100170217
RNAcentral	URS000002A4F1 — ncRNA, 120 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 0

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

None — 0 exons

Expression profiles

Top tissues by expression

0 total, by Bgee expression score (0-100, higher = more expressed):

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

Canonical reviewed UniProt: None (reviewed: )

All UniProt accessions (0):

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 0 (showing top):

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	0
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

0 predictions. Top by Δscore:

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1001364901 (19:50140667 C>T), RS1003433500 (19:50140720 T>G), RS1003817792 (19:50139198 C>G,T), RS1004710567 (19:50141188 G>A,C,T), RS1005217249 (19:50140879 C>T), RS1005810944 (19:50140326 G>A,C), RS1006719658 (19:50139933 A>C,G,T), RS1007227048 (19:50139853 G>A,T), RS1010568867 (19:50140134 T>A,C,G), RS1011798003 (19:50140457 T>C), RS1012075223 (19:50140612 T>C,G), RS1012128944 (19:50140700 C>A,G,T), RS1013076284 (19:50140213 T>C,G), RS1013127985 (19:50140283 A>C,T), RS1013419762 (19:50140704 G>A,C,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
propionaldehyde	decreases expression	1
bisphenol A	affects expression	1
2-methyl-4-isothiazolin-3-one	increases expression	1
didecyldimethylammonium	decreases expression	1
Rotenone	decreases expression	1
Silicon Dioxide	decreases expression	1
Tobacco Smoke Pollution	increases expression	1
Cadmium Chloride	decreases expression	1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.